Melanoma Practice Review, Issue 2

In this issue:

COVID-19:
- Cancer immunotherapy
- Melanoma treatment with checkpoint inhibitors
- Skin cancer consultation and surgery
ESMO recommendations for metastatic melanoma
TGA – new registrations
TGA alert – hydrochlorothiazide and risk of non-melanoma skin cancer
KIT and melanoma: clinical implications
Toxicity in combination immune checkpoint inhibitor and radiation
Gene-expression profiling in cutaneous melanoma
Prostate cancer risk in patients with melanoma
COVID-19 resources
Conferences, workshops and CPD

Please login below to download this issue (PDF)

Subscribe